Thermo Fisher Scientific Inc.

BUL:TN8 Rapporto sulle azioni

Cap. di mercato: €205.3b

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Thermo Fisher Scientific Crescita futura

Future criteri di controllo 1/6

Thermo Fisher Scientific is forecast to grow earnings and revenue by 10.6% and 5.6% per annum respectively. EPS is expected to grow by 11% per annum. Return on equity is forecast to be 17.5% in 3 years.

Informazioni chiave

10.6%

Tasso di crescita degli utili

11.0%

Tasso di crescita dell'EPS

Life Sciences crescita degli utili0%
Tasso di crescita dei ricavi5.6%
Rendimento futuro del capitale proprio17.5%
Copertura analitica

Good

Ultimo aggiornamento06 Aug 2024

Aggiornamenti recenti sulla crescita futura

Recent updates

Previsioni di crescita degli utili e dei ricavi

BUL:TN8 - Stime future degli analisti e dati finanziari passati (USD Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/202649,0938,0399,47610,64120
12/31/202545,7416,9258,6439,49525
12/31/202442,9556,1426,8398,00925
6/29/202442,3466,2207,9639,348N/A
3/30/202442,4926,0347,5608,928N/A
12/31/202342,8575,9956,9278,406N/A
9/30/202343,4215,9416,5468,170N/A
7/1/202343,5245,7215,8547,693N/A
4/1/202343,8076,0245,6207,681N/A
12/31/202244,9156,9506,9119,154N/A
10/1/202244,1677,0325,6008,124N/A
7/2/202242,8207,4396,3368,837N/A
4/2/202241,1237,6037,0019,536N/A
12/31/202139,2117,7256,7899,312N/A
10/2/202139,0598,5657,91610,194N/A
7/3/202138,2508,5968,13210,252N/A
4/3/202135,8947,9248,0629,911N/A
12/31/202032,2186,3756,8158,289N/A
9/26/202028,4974,8795,6866,863N/A
6/27/202026,2483,7064,2455,272N/A
3/28/202025,6473,6693,7024,680N/A
12/31/201925,5423,6964,0474,973N/A
9/28/201925,2203,5923,9404,861N/A
6/29/201924,8683,5414,0864,964N/A
3/30/201924,6303,1744,2735,114N/A
12/31/201824,3582,9383,7854,543N/A
9/29/201823,8982,5703,9194,608N/A
6/30/201823,0942,3953,6894,317N/A
3/31/201822,0062,256N/A3,722N/A
12/31/201720,9182,228N/A4,005N/A
9/30/201719,8242,330N/A3,344N/A
7/1/201719,1992,270N/A3,220N/A
4/1/201718,7442,174N/A3,284N/A
12/31/201618,2742,025N/A3,258N/A
10/1/201617,9731,999N/A3,281N/A
7/2/201617,6062,003N/A3,220N/A
4/2/201617,3411,998N/A3,072N/A
12/31/201516,9651,980N/A2,942N/A
9/26/201516,8061,978N/A2,543N/A
6/27/201516,8541,971N/A2,475N/A
3/28/201516,9051,738N/A2,598N/A
12/31/201416,8901,896N/A2,620N/A
9/27/201415,8641,635N/A2,394N/A
6/28/201414,8841,482N/A2,224N/A
3/29/201413,8021,481N/A1,814N/A
12/31/201313,0901,279N/A2,011N/A
9/28/201312,8831,322N/A1,942N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: TN8's forecast earnings growth (10.6% per year) is above the savings rate (3%).

Guadagni vs Mercato: TN8's earnings (10.6% per year) are forecast to grow slower than the BG market (13.5% per year).

Guadagni ad alta crescita: TN8's earnings are forecast to grow, but not significantly.

Ricavi vs Mercato: TN8's revenue (5.6% per year) is forecast to grow slower than the BG market (24.5% per year).

Ricavi ad alta crescita: TN8's revenue (5.6% per year) is forecast to grow slower than 20% per year.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: TN8's Return on Equity is forecast to be low in 3 years time (17.5%).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y